These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5213)

  • 21. A common immunoregulatory locus controls susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis in BALB/c mice.
    Teuscher C; Hickey WF; Grafer CM; Tung KS
    J Immunol; 1998 Mar; 160(6):2751-6. PubMed ID: 9510176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of novel immunosuppressant FK 506 in acute experimental allergic encephalomyelitis].
    Deguchi K; Takeuchi H; Miki H; Yamada A; Touge T; Terada S; Nishioka M
    No To Shinkei; 1990 Apr; 42(4):391-7. PubMed ID: 1697182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of experimental allergic encephalomyelitis in guinea pigs by treatment with magnetophores].
    Zhitnukhin IuL; Zatepiakin IuS; Karasik OA
    Biull Eksp Biol Med; 1980 Dec; 90(12):713-5. PubMed ID: 7470609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.
    Santambrogio L; Hochwald GM; Saxena B; Leu CH; Martz JE; Carlino JA; Ruddle NH; Palladino MA; Gold LI; Thorbecke GJ
    J Immunol; 1993 Jul; 151(2):1116-27. PubMed ID: 8335893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression and reversal of allergic encephalomyelitis in guinea pigs with a non-encephalitogenic analogue of the tryptophan region of the myelin basic protein.
    Hashim GA; Sharpe RD; Carvalho EF; Stevens LE
    J Immunol; 1976 Jan; 116(1):126-30. PubMed ID: 54384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IgM repertoire reactions to MBP/CFA immunization reflect the individual status of EAE susceptibility.
    Fesel C; Coutinho A
    J Autoimmun; 2000 Jun; 14(4):319-24. PubMed ID: 10882058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide.
    Teitelbaum D; Meshorer A; Hirshfeld T; Arnon R; Sela M
    Eur J Immunol; 1971 Aug; 1(4):242-8. PubMed ID: 5157960
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.
    Levine S; Sowinski R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):309-18. PubMed ID: 603323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment.
    Hughes D; Keith AB; Mertin J; Caspary EA
    Clin Exp Immunol; 1980 Jun; 40(3):523-31. PubMed ID: 7418264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclophosphamide inhibition of experimental allergic encephalomyelitis in guinea pigs.
    Field EJ
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):171-7. PubMed ID: 5365230
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental allergic encephalomyelitis in the guinea pig. Failure to suppress with crude human chorionic gonadotrophin.
    Caspary EA; Hughes D
    J Neurol Sci; 1977 Oct; 34(1):53-62. PubMed ID: 915538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.
    Smith ME; Amaducci LA
    Neurochem Res; 1982 May; 7(5):541-54. PubMed ID: 6750429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental allergic encephalomyelitis. V. Therapeutic attempts with immunosuppressive and antiinflammatory drugs.
    Anghelescu N; Petrescu A; Chimion D
    Neurol Psychiatr (Bucur); 1979; 17(2):99-105. PubMed ID: 482840
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection against experimental allergic encephalomyelitis in guinea pigs by bacterial lipopolysaccharide.
    Nagasawa K; Mori R
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):332-42. PubMed ID: 338506
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-molecular-weight enzyme inhibitors suppress the development of experimental allergic encephalomyelitis.
    Aoyagi T; Wada T; Nagai M; Sakaguchi H; Osanai T; Nagai Y; Umezawa H
    Experientia; 1984 Dec; 40(12):1405-7. PubMed ID: 6510498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cytarabine and adamantoyl cytarabine on experimental allergic encephalomyelitis in rats.
    Greig ME; Gibbons AJ
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):364-9. PubMed ID: 5371187
    [No Abstract]   [Full Text] [Related]  

  • 37. SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITIES.
    BRANDRISS MW; SMITH JW; FRIEDMAN RM
    Ann N Y Acad Sci; 1965 Mar; 122():356-68. PubMed ID: 14313495
    [No Abstract]   [Full Text] [Related]  

  • 38. [ASPARAGINASE IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. 3. ASPARAGINASE IN THE LYMPH NODES AND SPLEEN IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS].
    TURSKY T; VALOVICOVA E
    Bratisl Lek Listy; 1965 Jan; 45():3-8. PubMed ID: 14275927
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of experimental allergic encephalomyelitis in guinea pigs by spergualin and 15-deoxyspergualin.
    Nemoto K; Abe F; Takita T; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1987 Aug; 40(8):1193-4. PubMed ID: 3680030
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of imuran (azathioprine) on susceptibility of guinea pigs to allergic encephalomyelitis.
    Field EJ
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):138-41. PubMed ID: 6030233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.